{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T23:10:13Z","timestamp":1759014613650,"version":"3.44.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.genhosppsych.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:19:02Z","timestamp":1683321542000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Psychopharmaphobia: Elevated fear of antidepressant medication among patients with major depression and breast cancer"],"prefix":"10.1016","volume":"83","author":[{"given":"John C.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Hellerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Falabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Levenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine D.","family":"Crew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pon.3409","article-title":"Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments","volume":"23","author":"Krebber","year":"2014","journal-title":"Psychooncology"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The epidemiology of depression across cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0015","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jnci\/djy177","article-title":"Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review","volume":"110","author":"Carreira","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1200\/JOP.2016.011072","article-title":"Management of depression in patients with cancer: a clinical practice guideline","volume":"12","author":"Li","year":"2016","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0033-3182(89)72268-4","article-title":"Consultation-liaison psychiatry: a historical overview","volume":"30","author":"Schwab","year":"1989","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-018-4994-5","article-title":"A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer","volume":"173","author":"Blanco","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/030089161309900511","article-title":"Treatment of depression in patients with breast cancer: a critical review","volume":"99","author":"Callari","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0040","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"year":"2016","series-title":"The guide to interpersonal psychotherapy","author":"Weissman","key":"10.1016\/j.genhosppsych.2023.05.005_bb0045"},{"year":"2015","series-title":"Structured clinical interview for DSM-5 \u2013 Research version","author":"First","key":"10.1016\/j.genhosppsych.2023.05.005_bb0050"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-199201000-00007","article-title":"Adequacy and duration of antidepressant treatment in primary care","volume":"30","author":"Katon","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3399\/bjgp09X395067","article-title":"Initiation of antidepressant therapy: do patients follow the GP\u2019s prescription?","volume":"59","author":"Van Geffen","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0075","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0080","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/07347332.2014.955239","article-title":"Individual counseling is the preferred treatment for depression in breast cancer survivors","volume":"32","author":"Wu","year":"2014","journal-title":"J Psychosoc Oncol"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4088\/JCP.14m09640","article-title":"Treatment preferences of psychotherapy patients with chronic PTSD","volume":"77","author":"Markowitz","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4088\/JCP.08m04371","article-title":"Patient preference as a moderator of outcome for chronic depression treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination","volume":"70","author":"Kocsis","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1037\/0022-006X.75.1.194","article-title":"Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials","volume":"75","author":"Iacoviello","year":"2007","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jamapsychiatry.2015.2879","article-title":"True evidence-based care for posttraumatic stress disorder in military personnel and veterans","volume":"73","author":"Steenkamp","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000323615","article-title":"Treatment preferences among depressed patients after acute coronary syndrome: the COPES observational cohort","volume":"80","author":"Burg","year":"2011","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0110","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1001\/jama.288.22.2836","article-title":"Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial","volume":"288","author":"Un\u00fctzer","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archinternmed.2010.29","article-title":"Enhanced depression care for acute coronary syndrome patients with persistent depressive symptoms. Coronary psychosocial evaluation studies (COPES) randomized controlled trial","volume":"170","author":"Davidson","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1207\/s15324796abm3002_9","article-title":"The effect of patient preference on depression treatment in primary care","volume":"30","author":"Lin","year":"2005","journal-title":"Ann Behav Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0125","first-page":"146","article-title":"Treatment preferences among depressed primary care patients","volume":"21","author":"Dwight-Johnson","year":"2006","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/archpsyc.55.5.452","article-title":"Treatment of depressive symptoms in human immunodeficiency virus-positive patients","volume":"55","author":"Markowitz","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/ajp.154.4.523","article-title":"Medication and psychotherapy in the treatment of bulimia nervosa","volume":"154","author":"Walsh","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00048670903107559","article-title":"The elephant on the couch: side-effects of psychotherapy","volume":"43","author":"Berk","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0145","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00406-018-0931-1","article-title":"It can\u2019t hurt, right? Adverse effects of psychotherapy in patients with depression","volume":"269","author":"Moritz","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0150","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(99)00092-0","article-title":"Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability","volume":"58","author":"Anderson","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0160","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/pds.1719","article-title":"Antidepressant medication use and breast cancer risk","volume":"18","author":"Wernli","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen; a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0170","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1055-9965.EPI-15-1063","article-title":"Depression, antidepressant use, and postmenopausal breast cancer risk","volume":"25","author":"Brown","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S1478951506060068","article-title":"Psychological morbidity and quality of life in Australian women with advanced breast cancer: a cross-sectional survey","volume":"4","author":"Grabsch","year":"2006","journal-title":"Palliative Support Care"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/wps.20701","article-title":"A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression","volume":"19","author":"Cuijpers","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1440-1614.1999.00565.x","article-title":"A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice","volume":"33","author":"Freed","year":"1999","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0190","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/pon.3864","volume":"25","author":"Andersen","year":"2016","journal-title":"Psychooncology"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0893-133X(00)00218-9","article-title":"Enhancing informed consent for research and treatment","volume":"24","author":"Dunn","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-med-070909-182545","article-title":"Pharmacogenetics of endocrine therapy for breast cancer","volume":"62","author":"Higgins","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.breast.2010.11.003","article-title":"Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes","volume":"20","author":"Singh","year":"2011","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.genhosppsych.2023.05.005_bb0215","doi-asserted-by":"crossref","first-page":"pkab018","DOI":"10.1093\/jncics\/pkab018","article-title":"Adverse events and perception of benefit from duloxetine for treating aromatase inhibitor-associated arthralgias","volume":"5","author":"Schnell","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4088\/JCP.v65n0410","article-title":"Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study","volume":"65","author":"Grassi","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v67n0217","article-title":"A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression","volume":"67","author":"Musselman","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0230","first-page":"195","article-title":"A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression","volume":"122","author":"M\u00f6slinger-Gehmayr","year":"2000","journal-title":"Zentralbl Gynakol"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0235","first-page":"83","article-title":"Sertraline effectiveness and safety in depressed oncological patients","volume":"16","author":"Torta","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1012518831494","article-title":"Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline","volume":"70","author":"Pezzella","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-007-9841-z","article-title":"Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy","volume":"112","author":"Navari","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0250","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.pnpbp.2011.11.010","article-title":"Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial","volume":"36","author":"Park","year":"2012","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol Health"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/picr.PICR_147_16","article-title":"Informed consent process: a step further towards making it meaningful!","volume":"8","author":"Kadam","year":"2017","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0265","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM200005183422001","article-title":"The acute treatment of chronic major depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination","volume":"342","author":"Keller","year":"2000","journal-title":"NEJM"},{"year":"2012","series-title":"Motivational interviewing: Helping people change","author":"Miller","key":"10.1016\/j.genhosppsych.2023.05.005_bb0270"},{"year":"1987","series-title":"Cognitive therapy of depression","author":"Beck","key":"10.1016\/j.genhosppsych.2023.05.005_bb0275"},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0280","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients","volume":"28","author":"Hershman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2023.05.005_bb0285","first-page":"20","article-title":"Better living through chemistry?","volume":"124","author":"Coles","year":"1997","journal-title":"Commonweal."},{"key":"10.1016\/j.genhosppsych.2023.05.005_bb0290","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.0022-3840.2004.00117.x","article-title":"Merchandising madness: pills, promises, and better living through chemistry","volume":"38","author":"Rubin","year":"2004","journal-title":"J Pop Cult"},{"year":"1993","series-title":"Listening to Prozac","author":"Kramer","key":"10.1016\/j.genhosppsych.2023.05.005_bb0295"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834323000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834323000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:55:54Z","timestamp":1759013754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834323000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":58,"alternative-id":["S0163834323000804"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2023.05.005","relation":{},"ISSN":["0163-8343"],"issn-type":[{"type":"print","value":"0163-8343"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychopharmaphobia: Elevated fear of antidepressant medication among patients with major depression and breast cancer","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}